<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01735136</url>
  </required_header>
  <id_info>
    <org_study_id>INSAN-HP-BS</org_study_id>
    <nct_id>NCT01735136</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of InSan Bamboo Salt on Improvement of Helicobacter Pylori Infection</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chonbuk National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chonbuk National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators performed a 4-week, randomized, double-blind, placebo-controlled human
      trial to evaluate the efficacy and safety of InSan Bamboo Salt on improvement of Helicobacter
      pylori infection. The investigators measured improvement of Helicobacter pylori infection
      parameters , including 14C-UBT(Urea breath test), and subjects' symptoms, and monitored their
      blood pressure.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2012</start_date>
  <completion_date type="Anticipated">June 2013</completion_date>
  <primary_completion_date type="Actual">November 2012</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in 14C-UBT(Urea breath test)</measure>
    <time_frame>4 weeks</time_frame>
    <description>14C-UBT(Urea breath test) was measured in study visit 1(0 week) and visit 3(4 week).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in subjects' symptoms</measure>
    <time_frame>4 weeks</time_frame>
    <description>subjects' symptoms was measured in study visit 1(0 week) and visit 3(4 week).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Helicobacter Pylori Infection</condition>
  <arm_group>
    <arm_group_label>InSan Bamboo Salt</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>InSan Bamboo Salt</intervention_name>
    <description>InSan Bamboo Salt (10g/day)</description>
    <arm_group_label>InSan Bamboo Salt</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo (10g/day)</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males and females 19-65 years old

          -  14C-UBT test â‰¥ 100 cpm

          -  Endoscopy results showing gastritis

          -  Able to give informed consent

        Exclusion Criteria:

          -  Diagnosed of gastrointestinal disease such as ulcer, cancer, more than 10 erosions

          -  Taken antibiotics and stomach medicines such as steroid, bismuth compound, H2-receptor
             antagonist and proton pump inhibitor within 2 weeks

          -  Allergic or hypersensitive to any of the ingredients in the test products

          -  History of reaction to any of the test products or of gastrointestinal diseases such
             as Crohn's disease or gastrointestinal surgery

          -  History of alcohol or substance abuse

          -  Participation in any other clinical trials within past 2 months

          -  Laboratory test, medical or psychological conditions deemed by the investigators to
             interfere with successful participation in the study

          -  Pregnant or lactating women etc.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Clinical Trial Center for Functional Foods; Chonbuk National University Hospital</name>
      <address>
        <city>Jeonju</city>
        <state>Jeollabuk-do</state>
        <zip>560-822</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seung-Ok Lee, MD., PhD</last_name>
      <phone>82-63-250-1289</phone>
      <email>hyangim100@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>November 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 23, 2012</study_first_submitted>
  <study_first_submitted_qc>November 23, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 28, 2012</study_first_posted>
  <last_update_submitted>November 27, 2012</last_update_submitted>
  <last_update_submitted_qc>November 27, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 29, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chonbuk National University Hospital</investigator_affiliation>
    <investigator_full_name>Soo-Wan Chae</investigator_full_name>
    <investigator_title>Principal Investigator, Clinical Trial Center for Functional Foods</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Helicobacter Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

